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X-linked intellectual disability (XLID) refers to a clinically and genetically heterogeneous neuro-
developmental disorder, in which males are more heavily affected than females. Among the syn-
dromic forms of XLID, identified by additional clinical signs as part of the disease spectrum, the
association between XLID and severe myopia has been poorly characterized. We used whole
exome sequencing (WES) to study two Italian male twins presenting impaired intellectual func-
tion and adaptive behavior, in association with severe myopia and mild facial dysmorphisms.
WES analysis detected the novel, maternally inherited, mutation c.916G > C (G306R) in the X-
linked heparan sulfate 6-O-sulfotransferase 2 (HS6ST2) gene. HS6ST2 transfers sulfate from aden-
osine 30-phosphate, 50-phosphosulfate to the sixth position of the N-sulphoglucosamine residue
in heparan sulfate (HS) proteoglycans. Low HS sulfation levels are associated with defective
optic disc and stalk morphogenesis during mammalian visual system development. The
c.916G>C variant affects the HS6ST2 substrate binding site, and its effect was considered “del-
eterious” by in-silico tools. An in-vitro enzymatic assay showed that the HS6ST2 mutant isoform
had significantly reduced sulphotransferase activity. Taken together, the results suggest that
mutant HS6ST2 is possibly involved in the development of myopia and cognitive impairment,
characteristics of the probands reported here.
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1 | INTRODUCTION
Intellectual disability (ID) is defined as a neurodevelopmental disorder
with onset before 18 years of age, characterized by IQ ≤ 70 and defi-
cit in at least two adaptive behaviors (eg, communication, self-care).1
ID occurs in approximately 1% to 3% of the population2 and has a
variety of environmental and genetic causes, which are frequently
present in combination with one another.3 Mild ID is typically
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associated with environmental features, while genetic factors have a
major influence in moderate, severe, and profound ID4; however, the
identification of factors contributing to ID etiology is complicated by
the extreme heterogeneity of this condition. Numeric and structural
chromosomal aberrations, as well as variants in at least 800 protein-
coding genes,3 explain approximately half of ID diagnoses, while the
etiological factors underlying the remaining cases are unknown. Muta-
tions in genes influencing ID can give rise to both syndromic and
non-syndromic forms of the condition. Syndromic ID includes a highly
heterogeneous group of phenotypes where ID occurs together with a
constellation of other features.5 ID gene density is particularly high on
the X chromosome, with more than 10% of all ID-related protein-
coding genes mapping to the X, establishing the condition referred to
as X-linked ID (XLID) that predominantly occurs in males6; overall,
30% more males are affected than females.7
Here, we report two monozygotic male twins of a triplet preg-
nancy with clinical diagnosis of syndromic ID combined with severe
myopia and mild dysmorphic features.
High myopia is a prominent refractive error. Gupta et al. reviewed
the candidate genes related with inherited myopia and reported only
two forms of non-syndromic condition, one involving ZNF644 and the
other related to SCO2 gene.8 High myopia and severe ID, presenting
as isolated manifestations without other relevant dysmorphic or mal-
formative features, have never been previously associated with a
known clinical condition. Conversely, they have been identified in
many syndromes, such as Donnai-Barrow or Cohen syndromes, as part
of a broad range of clinical signs affecting many parts of the body.
Genetic investigation of the triplets and their immediate family
revealed a mutation in the heparan sulfate 6-O-sulfotransferase 2
(HS6ST2) gene on the X chromosome, predicted to detrimentally influ-
ence protein function. in vitro assays confirmed the deleterious effect
of the mutation on HS6ST2 enzyme activity. Hence, mutations in
HS6ST2 represent a potential new cause of syndromic XLID.
2 | MATERIALS AND METHODS
2.1 | Study aim, design, and setting
The aim of this study was to screen for the genetic basis of the pheno-
type of two identical twins presenting at our hospital with ID and
severe myopia. Following clinical examination, whole exome sequenc-
ing (WES) and functional analysis of the potential causal mutation
were performed. The study setting was the Fondazione IRCCS Ca'
Granda Ospedale Maggiore Policlinico, Milano, Italy. Appropriate
informed consent for WES analysis for research purposes was
obtained from all family members.
Parental approval was also obtained for the inclusion of the
genetic data of all family members in a scientific publication.
2.2 | Whole exome sequencing
Genomic DNA was extracted from peripheral blood samples of all
family members using a QIAamp DNA mini kit (Qiagen, Hilden, Ger-
many), according to the manufacturer's instructions. DNA was
quantified using a NanoDrop spectrophotometer (Thermo Fisher Sci-
entific, Waltham, MA). A SureSelect Clinical Research Exome V5 kit
(Agilent, Santa Clara, CA) was used to perform next-generation
sequencing (NGS) analyses of DNA samples (2 μg). Libraries were ana-
lyzed by paired-end NGS (NextSeq 550; Illumina, San Diego, CA).
Sequences were aligned to the human genome reference
(GRCh37/hg19). WES data were analyzed using Illumina VariantStu-
dio data analysis software and annotated and filtered with wANNO-
VAR (http://wannovar.wglab.org).
Autosomal and X-linked recessive transmissions were first investi-
gated as potential inheritance patterns. De novo variants were also
considered. Accordingly, we set the variant calling parameters as fol-
lows: PassFilter = ON; Quality>30; Read Deph>8; Alt Variant
Freq>25. We first focused our analysis on consensus splice-site
changes, non-synonymous variants, and insertions/deletions in exonic
regions. We also assumed that the alternative allele should have a fre-
quency lower than 0.01 (based on Exome Aggregation Consortium
[ExAC] all frequency) or that it should be absent from the ExAC, 1000
Genomes, dbSNP132, COSMIC and ClinVar databases. Output files
from VariantStudio are provided as Supporting Information Appendix
S1, S2, and S3 (autosomal recessive, X-linked recessive and de novo
variants, respectively).
HS6ST2 variant, identified in probands FII-1 and FII-2 and in their
mother, was confirmed by Sanger sequencing using the following
primers: Forward, 50-AGCAGCGGCTCCAGGGGAAG-30 and Reverse,
50-GTCAGGGTGCGCGCTAGGTC-30.
2.3 | Bioinformatic analyses
In silico prediction of the functional effect of the c.916G>C mutation
on the HS6ST2 gene was performed using the “Mutation Taster” tool.
At the protein level, the consequences of the Gly306Arg substitution
on HS6ST2 tertiary structure were evaluated using Phyre2 software
(Protein Homology-fold Recognition Server; www.sbg.bio.ic.ac.uk/
phyre2/). Wild-type and mutated HS6ST2 3D structures were mod-
elled.9 These analyses were implemented using Phyre investigator, a
workbench analysis tool with additional features for investigation of
models created using Phyre2. All *.pdb files generated using Phyre2
were loaded and visualized with ChemDraw (version 8; Cambridge
Software; PerkinElmer, Inc., Waltham, Massachusetts).
2.4 | HS6ST2 site-directed mutagenesis
The mammalian pReceiver-M12 Ampr vector containing the full length
HS6ST2 cDNA isoform (NM_001077188.1, ENST00000521489.5)
fused to an N-terminal 3× Flag-tag (tebu-bio) was used as template to
generate a HS6ST2 c.916G>C mutant sequence, by site-directed muta-
genesis (QuikChange II Site-Directed Mutagenesis Kit; Stratagene, San
Diego, CA). Primers used to obtain the G>C nucleotide substitution
were as follows: Forward, 50-GCCCTCCGT GGTGGACCGCAAGCGC-
GACGCCAG-30 and Reverse, 50-CTGGCGTCGCGCTTGCGGGTGGA-
CACGGAGGGC-30.
The plasmid expressing the Gly306Arg mutant was transformed
into Escherichia coli strain DH5α for amplification. The presence of the
c.916G>C transversion inside the plasmid was confirmed by Sanger
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sequencing using the following primers: Forward, 50-
GCCCTCCGTGGTGGACCGCAAGCGCGACGCCAG-30 and Reverse,
50-CTGGCGTCGCGCTTGCGGTCCACCACGGAGGGC-30.
2.5 | Immunoblot assay
Wild-type and mutant (G306R) plasmids were transiently transfected
into HEK293T (human embryonic kidney) cells cultured in Dulbecco’s
Modified Eagle’s Medium (DMEM), using Lipofectamine 2000 (Invitro-
gen, Carlsbad, CA) according to the manufacturer's protocol. Total pro-
tein extracts (20 μg) from cell lysates were electrophoretically
separated on 10% denaturing polyacrylamide gels and then transferred
to Polyvinylidene difluoride (PVDF) membranes (Roche, Basilea, Swit-
zerland). A high range SigmaMarker (Sigma-Aldrich, Saint Louis, MO;
molecular weight range, 36 000-200 000 kDa) was used to character-
ize protein migration. Membranes were blocked in Tris-buffered saline
with 0.1% Tween 20 containing 5% non-fat dried milk and reacted
overnight at 4C with the primary monoclonal antibody, anti-FLAG
mouse M2 clone (Sigma-Aldrich) diluted 1:2000, and anti-beta Actin
antibody ab8226 (Abcam, Cambridge, UK), diluted 1:1000. After rinsing,
filters were incubated with horseradish peroxidase-conjugated goat
anti-mouse IgG secondary antibody (Santa Cruz), diluted 1:10000. Sig-
nals were developed using the enhanced chemiluminescent horseradish
peroxidase (HRP) substrate Westar ETA C ultra (Cyanagen, Bologna,
Italy), and specific protein bands were revealed using the G:BOX Chemi
XT4 gel doc system (Syngene, Frederick, MD).
2.6 | Assay of HS6ST2 activity
The enzymatic activity of HS6ST2 was assayed in cell extracts from
either wild-type or mutant (G306R) transiently transfected HEK293T
cells, incubated in DMEM for 48 hours. The enzyme assay was per-
formed according to Habuchi et al.,10 with minor modifications. To
obtain cell extracts, cells were washed twice with cold phosphate-
buffered saline, harvested, and then resuspended in the following
Buffer A: 10 mM Tris/HCl, pH 7.2, 0.15 M NaCl, 10 mM MgCl2,
2 mM CaCl2, 20% (w/v) glycerol, and 0.5% (w/v) Triton X-100. After
stirring for 1 hour at 4C in a rotatory shaker, cell homogenates were
centrifuged at 10000 × g for 30 minutes at 4C. Supernatants (cell
extracts) were carefully collected, and their protein content was
determined,11 followed by assay of HS6ST2 activity.
The reaction mixture (50 μL, final volume) contained 50 mM
imidazole-HCl (pH 6.8), 75 μg/mL protamine chloride, 150 mM NaCl,
20 mM NaF, 500 μM HS (as glucuronic acid), 10-30 μg cell extract
protein, and 2 μM [35S] PAPS (2 Ci/mmol). When indicated, dithio-
threitol (DTT) (2-10 mM) was added. The reaction mixtures were incu-
bated for 15-30 minutes at 37C, and then stopped by heating the
tubes at 100C for 1 minute. After cooling at 4C, chondroitin sulfate
A (50 nmol, as glucuronic acid) was added as a carrier to facilitate pre-
cipitation. The mixtures were then supplemented with four volumes
of 95% ethanol/1.3% (w/v) potassium acetate/0.5 mM ethylenediami-
netetraacetic acid (EDTA), mixed and maintained at −20C for
30 minutes. [35S]-labeled glycosaminoglycans were precipitated by
centrifugation (10 000 × g for 10 minutes at 4C), resuspended in
water and separated from unreacted [35S] PAPS and inorganic sulfate
using a Sephadex G-25 superfine column (Amersham Bioscience, Little
Chalfont Buckinghamshire, UK), following the manufacturer's instruc-
tions. The eluate, containing [35S]-labeled polysaccharides, was col-
lected by centrifugation and the radioactivity was measured by liquid
scintillation using a beta-counter (TRICARB 2100-TR; Perkin Elmer
Life Sciences, Boston, Massachusetts).
3 | RESULTS
3.1 | Probands
An Italian family composed of healthy non-consanguineous parents
(FI-1 and FI-2), two affected male twins (FII-1 and FII-2) and one
healthy brother (FII-3) (Figure 1) was investigated. The triplets were
born at 30 weeks' gestation by emergency cesarean section, due to
fetal distress. The pregnancy, resulting from in vitro fertilization, was
dichorionic-triamniotic and the twins were two identical (FII-1 e FII-2)
and one brother (FII-3). The probands came to our attention when
they were 5 years old, after a diagnosis of severe psychomotor delay.
Karyotype and comparative genomic hybridization (CGH) array results
were normal, and they were negative for FMR1 repeat expansion. The
clinical features of the probands are detailed in Table 1. Both had neu-
rodevelopmental impairment, classified as “severe” according to the
Griffith scale (score = 34), and speech delay. They began walking at
2 years old and could speak only poorly at 5 years old. A routine
growth checkup at 5 years old revealed weight in the 10th and height
in the 25th percentiles. In the first year of life, they suffered from
FIGURE 1 Pedigree of individuals carrying the HS6ST2 p.G306R
(c.916G > C) variant in this study. Photographs of the two affected
monozygotic twins (FII-1 and FII-2) are presented. Filled symbols
represent symptomatic individuals, open symbols represent
unaffected individuals, and the open symbol with a black dot
represents an individual who carries the mutation. Monozygotic twins
are recognizable from the connected symbol [Colour figure can be
viewed at wileyonlinelibrary.com]
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febrile seizures, with evidence of epileptiform electroencephalography
(EEG) abnormalities, which presented as diffuse and irregular spikes.
Brain magnetic resonance imaging scan showed mild lateral ventricu-
lar enlargement. Both the probands exhibited high myopia (−6 diop-
ters, compared with −0.75 diopters for their healthy sibling),
accompanied by chorioretinopathy. They had mild dysmorphic facial
features (Figure 1), including triangular face, large forehead, deeply set
and halonated eyes, straight and downward-slanting eyebrows, thin
lips with downturned corners, slight prognathism, pointed chin, and
small low-set and malrotated ears. At the last checkup, performed at
the age of 10, the children presented with feeding difficulties and uri-
nary incontinence. Myopia remained severe but stable, and epilepsy
was no longer present.
Biochemical analyses, performed at 5 years old, revealed an ele-
vated lactate/pyruvate ratio in FII-1 patient (34.11; reference value: <
25), and FII-2 patient had an increased blood lactic acid value (23 mg/
dL; control range: 6.3-18.9 mg/dL). Furthermore, alanine levels were
elevated in both probands (values not available). Ranges of serum
pyruvate and excreted urine organic acids were normal. At 10 years
old, blood lactic acid values were only slightly increased in both
patients (FII-1:1.6 mM; FII-2:1.4 mM; reference range: 0-1.3 mM).
Notably, the two affected twins had low glycemic scores (FII-
1:67 mg/dL; FII-2:68 mg/dL; normal range: 70-110 mg/dL).
Input of these clinical and genetic evidences into the Face2Gene
next-generation phenotyping application indicated a possible mild cor-
relation with the phenotype of Brooks Wisniewski Brown (BWB) syn-
drome (OMIM: #300612).
3.2 | Mutation analysis by NGS
Using WES analysis, we identified the hemizygous single-nucleotide
variant, c.916G>C (p.G306R), in the HS6ST2 gene (RefSeq
NM_001077188.1; NP_001070656.1) on chromosome Xq26.2. The
enzyme encoded by HS6ST2 is responsible for the transfer of sulfate
from adenosine 30-phosphate, 50-phosphosulfate (PAPS) to the sixth
position of the N-sulfoglucosamine (GlcNS) residue in heparan sulfate
(HS) proteoglycans (HSPGs). Two different splice isoforms of human
HS6ST2 have been identified and exhibit tissue-specific localization: full
length HS6ST2 is expressed in the eyes and brain during embryonic
development, and a short form of the gene, hHS6ST-2S, encoding
40 fewer amino acids, has been detected in the ovary, placenta, and
fetal kidney.12 Both isoforms catalyze the same sulfation reaction.13
The novel G>C transversion in HS6ST2 identified here changes a
GGC codon, encoding a non-polar glycine residue, to a CGC, which
encodes a positively charged arginine. The variant was present in the
affected triplets (FII-1 and FII-2), carried by the healthy mother, and
absent in both the father and the unaffected brother (FII-3) (Figure 1).
Sanger sequencing confirmed the findings of NGS and the segregation
of the transversion in the family. The “Mutation Taster” in silico pre-
diction tool classified the c.916G>C substitution as deleterious, with a
score of 1.000 (values close to 1 indicate a high “security” of predic-
tion). This substitution has never been reported in the main databases
of nucleotide variants, including dbSNP, 1000 Genomes, and Exac
(Appendix S1).
3.3 | In silico 3D modeling of the HS6ST2-G306R
protein
The G306R variant is located within the HS 6-O-sulfotransferase
domain of the HS6ST2 protein, between the 50-phosphosulfate-binding
site and the 30-phosphate-binding site (ENST00000521489.5). Three-
dimensional protein structures of wild-type HS6ST2 and the G306R
mutated variant were predicted with Phyre2 software, using the pri-
mary amino acid sequences as input (Figure 2). The G306R substitution
was predicted to cause a significant change in the concave surface of
the HS6ST2 protein, generating a deeper pocket with a smaller diame-
ter (diameter, 16.07 Å; greatest depth, 25.32 Å; Figure 2, panel B) rela-
tive to the wild-type structure (diameter, 23.31 Å; greatest depth,
17.41 Å; Figure 2, panel A). 3D conformation of the HS6ST2 6-O-
sulfotransferase domain functions to maintain contact between the sul-
fate donor, PAPS, and position 6 of the acceptor GlcNS of
HS. Changing the pocket surface, as well as the 3D structure, of the
HS6ST2 active site could result in modification of its enzyme activity.
Moreover, the G306R variant modifies protein conformation at the N-
terminus of HS6ST2, leading to a complete mis-localization of the type
II membrane protein signal-anchor domain (amino acids 5-27), which
may lead to a failure of the protein to anchor to the Golgi apparatus
membrane (Figure 2, panels C and D; amino acids corresponding to the
N-terminal domain are highlighted in light blue).
3.4 | In vitro assay of HS6ST2-G306R activity
To test whether G306R variant affects HS6ST2 enzyme expression
and/or activity, HEK293 cells were transiently transfected with the
empty vector (mock control) and with plasmids expressing wild-type
(HS6ST2-WT) or G306R mutant (HS6ST2-G306R) FLAG-HS6ST2. We
first analyzed the expression of recombinant wild-type and mutant
HS6ST2 proteins in HEK293 cells. Protein expression was undetectable
in mock-transfected cells but was evident in the HS6ST2-WT and
HS6ST2-G306R transfected cells. As shown in Figure 3A, the expres-
sion levels of the wild-type and mutant proteins were very similar.
Next, we examined HS6ST2 activity using HS as a substrate. In
mock-transfected HEK293 cells, HS6ST2 activity was 2.7  20.6
TABLE 1 Clinical features of the two affected twins
Clinical signs II-1 proband II-2 proband
Bifrontal narrowness +/− +/−
Low-set ears + +
Deeply set eyes + +
Myopia + +
Halonated eyes + +/−
Wide nose tip +/− +/−
Triangular face + +
Malar flatness + +
Thin upper lip + +/−
Neurodevelopmental delay + +
Febrile convulsions + +
Lateral ventricular enlargement + +
+ indicates the presence of the sign; +/− indicates that the feature is pre-
sent in a mild form.
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pmol/mg protein, min. In HS6ST2-WT transfected cells, 6-O-
sulfotransferase activity was approximately 4-fold higher at
13.2  31.1 pmol/ mg protein, min, (P = 0.0087, two-tailed t test),
reflecting over-expression of HS6ST2 from the transfection vector
the enzyme activity increased approximately 4-fold, to reach values of
13.2  31.1 pmol/ mg protein, min, (P = 0.0087, two-tailed t test).
Conversely, in HS6ST2-G306R transfected cells, 6-O-sulfotransferase
activity (5.1  i0.7 pmol/min, mg; P = 0.0063, two-tailed t test) was
considerably lower than in HS6ST2-WT transfected cells, demonstrat-
ing the importance of residue 306 for HS6ST2 enzymatic activity
(Figure 3B). Because HS6ST (but not HS2ST) isoforms are inhibited by
DTT 10, we next evaluated the effect of DTT on enzyme activity. As
shown in Figure 3C, DTT caused an approximately 3-fold decrease in
both wild-type and G306R enzyme activity, from 100% to
32%  13% (P = 0.0039, two-tailed t test) and from 38%  8% to
12%  2% (P = 0.047, two-tailed t test), respectively.
4 | DISCUSSION
In this study, WES was performed to characterize genetically two
affected monozygotic twins with an inconclusive clinical diagnosis. We
detected a novel pathogenic variant of the X-linked HS6ST2 gene
associated with a very unusual combination of syndromic ID and severe
congenital myopia. The deleterious effect of the mutant enzyme was
predicted using in silico tools and confirmed by an in vitro functional
assay.
The pedigree of the family included in this study was consistent
with the presence of a de novo variant or with recessive autosomal or
X-linked inheritance, and filtering processes revealed the missense
substitution c.916G>C in the HS6ST2 gene as the unique candidate
variant with high confidence. This variant was never been previously
reported and encodes HS6ST2, which transfers sulphate from PAPS to
the N-sulphoglucosamine (GlcNS) residue in HS proteoglycans.
Severe myopia is arbitrarily defined as short sightedness greater
than six diopters.14 It is usually an isolated disorder; however, more
rarely, it can be associated with syndromic conditions (eg, Stickler syn-
drome).15 Recently, Li and Zhang reviewed 131 forms of syndromic
myopia and reported that ID represents a variable feature in only a
small fraction of them, including muscular dystrophy-dystroglycanopa-
thy, spastic paraplegia with psychomotor retardation, homocystinuria,
retinal dystrophy (early onset), microphthalmia-syndromic 6, and
ichthyosis-spastic quadriplegia-mental retardation, along with the fol-
lowing syndromes: Cohen, Bohring-Opitz, Pitt-Hopkins, Poretti-Bolt-
shauser, Hamamy, Cornelia de Lange, and Danon. Of the 131 reported
FIGURE 2 Wild-type (A and C) and mutant (B and C) HS6ST2 3D structures, modeled using Phyre2 (protein homology-fold recognition engine).
In all panels, the amino acids forming the pocket surface are represented in light pink space-filled mode, and the variant position (306) is
indicated. A and B show pocket diameters (23.31 and 16.07 Å) and pocket depth values (17.41 and 25.32 Å) of the HS6ST2-WT (A) and
HS6ST2-G306R (B) isoforms, respectively. C and D demonstrate the mislocation of the N-terminal signal-anchor domain (amino acids 5-27), here
highlighted in blue, in the WT (C) and mutant (D) HS6ST2 [Colour figure can be viewed at wileyonlinelibrary.com]
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forms of syndromic myopia, 13 were X-linked, and among them only
Danon syndrome was sporadically associated with ID.16
HSPGs are ubiquitous components of the cell surface, extracellu-
lar matrix, and basement membranes, and interact with various ligands
to influence cell growth, differentiation, adhesion, and migration.13
Multiple intercellular signaling molecules are regulated by HSPGs,
including sonic hedgehog (SHH), bone morphogenetic protein (BMP),
retinoic acid (RA), and fibroblast growth factor (FGF), along with
Wingless/Integrated (WNT) signaling proteins, which are required for
proper mammalian retinal development. Specifically, SHH controls the
proximal-distal patterning of the optic vesicle; BMP and RA regulate
dorsal-ventral differentiation; FGF signaling is required for the region-
alization of the neural retina as well as for optic disc and fissure devel-
opment; and WNT is necessary for the specification of the retinal
pigmented epithelium. Low HSPG sulfation levels, as a result of muta-
tions in 6-O-sulfotransferase genes, such as HS6ST2, are implicated in
defective optic disc and stalk morphogenesis during mammalian visual
system development.13
Altered HS6ST2 expression has been identified in numerous
human cancers,17 and is reported to participate in the pathogenesis of
osteoarthritis and Kashin-Beck disease.18 To date, there is no evi-
dence of HS6ST2 involvement in Mendelian diseases.
The Face2Gene phenotyping tool identified a slight similarity of
the phenotype of the affected boys with that of BWB syndrome, a
condition described by Brooks et al., Morava et al., and Friez et al.19–22
ID, speech delay, and severe myopia in a context of mild dysmorphia
were the specific key features supporting the similarity. Moreover,
the three BWB patients described by Morava et al.21 presented with
increased blood lactate values in infancy, similar to the affected twins.
Despite this, WES analysis excluded the presence of pathogenic vari-
ants of the HUWE1 gene, which was identified by Friez et al. as a
causal gene for BWB.22 In addition, there were clinical discrepancies
between the affected probands and the BWB patients described in
the literature. The boys described by Brooks et al.19 presented with
spastic diplegia, optic and cerebellar atrophy, and entropion, which
were not noted in our cases; the majority of patients reported by
Morava20,21 exhibited regression, seizures, and corpus callosum hypo-
genesis that were not present in the patients described in the current
study. Given that BWB syndrome is an extremely rare disorder and
exhibits a high degree of clinical heterogeneity,19–22 it is possible that
BWB could be genetically heterogeneous and that the phenotype of
our patients represents a BWB-like disorder, caused by mutation in a
gene other than HUWE1. On the other hand, STRING network analy-
sis of protein associations (https://string-db.org) confirmed that the
E3 ubiquitin ligases HUWE1 and HS6ST2 do not share functional path-
ways, which does not support a BWB-like etiology for our patients.
The c.916G>C variant is predicted to modify the 3D conforma-
tion of both isoforms of the HS6ST2 enzyme, since it is in a region
common to both proteins. The mutation alters both the catalytic func-
tion of the enzyme and likely its localization in the membrane of the
Golgi apparatus. The HS6ST2-G306R functional assay demonstrated
a consistent reduction in its 6-O-sulfotransferase function; however,
since the assay was performed using total protein extracts and labeled
HS substrate, no details are available about the possible membrane
localization defect of the mutant isoform hypothesized to result from
the misfolding of the N-terminal residues.
HSPGs reside on the plasma membranes of all animal cells studied
to date and are major components of the extracellular matrix. Studies
of model organisms have demonstrated their importance in develop-
ment and normal physiology.23 HS have been specifically noted in eye
development, cranial axon guidance, and motor neuron migration.24,25
In a mouse model, abnormally low sulfation of HS allows normal
retinal neurogenesis and optic fissure closure; however, it leads to
defective optic disc and stalk development.24 Adult mutant animals
develop optic nerve aplasia/hypoplasia and exhibit retinal degenera-
tion.24 Although myopia is not directly related to optic nerve aplasia/
hypoplasia, but rather occurs if the eyeball is too long or the cornea is
too curved, a link may exist between the mutation detected in the
HS6ST2 gene and the severe myopia observed in the affected
children.
FIGURE 3 Expression and activity of HS6ST2 in mock, wild type and
G306R mutant cells. HEK293 cells were transiently transfected with
empty vector (mock), or with plasmids expressing wild-type FLAG-
HS6ST2 (WT), or mutant FLAG-G306R (G306R), and then subjected
to immunoblot analysis (A), and the HS6ST2 assay (B and C). A,
representative immunoblot image of HS6ST2 expression in mock, wild
type and G306R mutant cells. β-actin was used as loading control. B
and C, HS6ST2 activity in the cell extracts of mock, WT and G306R
cells. Enzyme activity was assayed as described in Materials and
Methods in the absence (B) or presence (C) of 10 mM dithiothreitol (+
DTT). In all cases, the reaction rate was linear with enzyme protein
and incubation time. Data are the mean  SD of three individual
assays. Statistical significance was assessed using two-tailed Student's
t test; **P < 0.01
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In conclusion, we identified a novel c.916G>C variant in the
HS6ST2 gene. The mutation caused a significantly reduction in
HS6ST2 6-O-sulfotransferase activity and was associated with a pre-
viously undescribed form of syndromic XLID with severe congenital
myopia. Although the phenotype of the probands in this study is
weakly similar to BWB, the underlying genetic cause differs. A
hypothesis could suggest possible loci and pathway heterogeneity in
BWB syndrome. Alternatively, HS6ST2 may cause a novel clinical con-
dition and be pivotal for the development of myopia and cognitive
impairment. Although the current report describes only a single pedi-
gree, it could be used by clinicians to facilitate recognition of similar
families and to provide a more accurate genetic counseling.
ACKNOWLEDGEMENTS
The authors thank the probands and their family for their participation
to the study, and for their generosity and patience. The authors wish
also to thank Prof. Hiroko Habuchi and Koji Kimata (Aichi Medical
University, Nagakute Aichi, Japan) for their helpful suggestions on the
HS6ST2 assay. This study was supported by “5X1000” 2015 from
Fondazione IRCCS Ca’ Granda, Ospedale Maggiore Policlinico, Milano
to Monica Miozzo.
Authors' contributions
D.M., L.P., and P.M. contributed to the clinical evaluation of the cases,
syndrome delineation and subject enrollment in the study; L.P., SM. T.,
and L.F. carried out WES data analysis and wrote the manuscript;
P.C. and L.F. performed WES experiments; M.C. modeled the mutant
HS6ST2 protein structure in-silico; L.P. and E.B. conducted HS6ST2 site-
directed mutagenesis; LA.H. and D.R. assayed HS6ST2 activity;
L.R. supervised the enzyme tests; SM. S. and M.M. managed all aspects of
the study and contributed to the writing of major parts of the manuscript.
CONFLICTS OF INTEREST
None of the authors have any conflicts of interest to declare.
ORCID
Leda Paganini https://orcid.org/0000-0003-1063-603X
Silvia M. Tabano https://orcid.org/0000-0002-5260-6691
Monica Miozzo https://orcid.org/0000-0002-6523-4575
REFERENCES
1. American Psychiatric Association. Diagnostic and Statistical Manual of
Mental Disorders (5th ed.) 2013. Washington, DC: Author.
2. Karam SM, Riegel M, Segal SL, et al. Genetic causes of intellectual dis-
ability in a birth cohort: a population-based study. Am J Med Genet A.
2015;167(6):1204-1214.
3. Chiurazzi P, Pirozzi F. Advances in Understanding–Genetic Basis of
Intellectual Disability. F1000Res. 2016;5(F1000 Faculty Rev):599.
4. Kaufman L, Ayub M, Vincent JB. The genetic basis of non-syndromic
intellectual disability: a review. J Neurodev Disord. 2010;2(4):182-209.
5. You J, Sobreira NL, Gable DL, et al. A syndromic intellectual disability
disorder caused by variants in TELO2, a gene encoding a component
of the TTT complex. Am J Hum Genet. 2016;98(5):909-918.
6. Lubs HA, Stevenson RE, Schwartz CE. Fragile X and X-linked intellec-
tual disability: four decades of discovery. Am J Hum Genet. 2012;90(4):
579-590.
7. McLaren J, Bryson SE. Review of recent epidemiological studies of
mental retardation: prevalence, associated disorders, and etiology.
Am J Ment Retard. 1987;92(3):243-254.
8. Gupta S, Chatterjee S, Mukherjee A, Mutsuddi M. Whole exome
sequencing: uncovering causal genetic variants for ocular diseases. Exp
Eye Res. 2017;164:139-150.
9. Kelley LA, Mezulis S, Yates CM, Wass MN, Sternberg MJ. The Phyre2
web portal for protein modelling, prediction and analysis. Nat Protoc.
2015;10:845-858.
10. Habuchi H, Habuchi O, Uchimura K, Kimata K, Muramatsu T. Determi-
nation of substrate specificity of sulfotransferases and glycosyltrans-
ferases (proteoglycans). Methods Enzymol. 2006;416:225-243.
11. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement
with the Folin phenol reagent. J Biol Chem. 1951;193:265-275.
12. Habuchi H, Miyake G, Nogami K, et al. Biosynthesis of heparan sulphate
with diverse structures and functions: two alternatively spliced forms of
human heparan sulphate 6-O-sulphotransferase-2 having different
expression patterns and properties. Biochem J. 2003;371(Pt 1):131-142.
13. Bishop JR, Schuksz M, Esko JD. Heparan sulphate proteoglycans fine-
tune mammalian physiology. Nature. 2007;446(7139):1030-1037.
14. Miller-Meeks MJ, Bennett SR, Keech RV, Blodi CF. Myopia induced
by vitreous hemorrhage. Am J Ophthalmol. 1990;109(2):199-203.
15. Gardiner CA, Woods CG. High myopia, and mild mental retardation in
three brothers. Clin Dysmorphol. 2000;9:43-46.
16. Li J, Zhang Q. Insight into the molecular genetics of myopia. Mol Vis.
2017;23:1048-1080. eCollection 2017.
17. Uhlén M, Fagerberg L, Hallström BM, et al. Tissue-based map of the
human proteome. Science. 2015;347(6220):1260419.
18. Wang W, Zhong B, Sun J, et al. Down-regulated HS6ST2 in osteoar-
thritis and Kashin-Beck disease inhibits cell viability and influences
expression of the genes relevant to aggrecan metabolism of human
chondrocytes. Rheumatology. 2011;50(12):2176-2186.
19. Brooks SS, Wisniewski K, Brown WT. New X-linked mental retarda-
tion (XLMR) syndrome with distinct facial appearance and growth
retardation. Am J Med Genet. 1994;51:586-590.
20. Morava E, Storcz J, Kosztolányi G. X-linked mental retardation syn-
drome: three brothers with the Brooks-Wisniewski-Brown syndrome.
Am J Med Genet. 1996;64(1):59-62.
21. Morava E, Rodenburg R, Hol F, et al. Mitochondrial dysfunction in
Brooks-Wisniewski-Brown syndrome. Am J Med Genet A. 2006;
140(7):752-756.
22. Friez MJ, Brooks SS, Stevenson RE, et al. HUWE1 mutations in
Juberg-Marsidi and Brooks syndromes: the results of an X-
chromosome exome sequencing study. BMJ Open. 2016;6(4):
e009537.
23. Sarrazin S, Lamanna WC, Esko JD. Heparan sulfate proteoglycans.
Cold Spring Harb Perspect Biol. 2011;3(7):a004952.
24. Cai Z, Grobe K, Zhang X. Role of heparan sulfate proteoglycans in
optic disc and stalk morphogenesis. Dev Dyn. 2014;243(10):1310-
1316.
25. Tillo M, Charoy C, Schwarz Q, et al. 2- and 6-O-sulfated proteoglycans
have distinct and complementary roles in cranial axon guidance and
motor neuron migration. Development. 2016;143(11):1907-1913.
SUPPORTING INFORMATION
Additional supporting information may be found online in the Sup-
porting Information section at the end of the article.
How to cite this article: Paganini L, Hadi LA, Chetta M, et al.
A HS6ST2 gene variant associated with X-linked intellectual
disability and severe myopia in two male twins. Clin Genet.
2018;1–7. https://doi.org/10.1111/cge.13485
PAGANINI ET AL. 7
